Related Experiment Video
Updated: Mar 3, 2026

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
Published on: April 21, 2022
[Retinal vein occlusions: diseases for the internist?]
D Prisco1, L Bertini, R Marcucci
1Centro di Riferimento Regionale per la Trombosi, Università degli Studi, Azienda Ospedaliera Careggi di Firenze. d.prisco@dfc.unifi.it
Insights
Central retinal vein occlusion, a common condition linked to internal medicine issues, is significantly associated with elevated levels of plasminogen activator inhibitor-1 (PAI-1), lipoprotein(a), and hyperhomocysteinemia, offering new insights into its pathogenesis.
Area of Science:
- Ophthalmology
- Internal Medicine
- Hematology
Context:
- Retinal vein occlusion (RVO) is a prevalent vascular disorder.
- Central retinal vein occlusion (CRVO) is the most common and impactful form.
- CRVO is frequently associated with systemic internal medicine conditions.
Purpose:
- To investigate novel hemostasis-related risk factors in CRVO pathogenesis.
- To evaluate the role of specific biomarkers in CRVO development.
- To explore potential prognostic and therapeutic implications of these findings.
Summary:
- While classic risk factors for CRVO are established, emerging research highlights hemostasis-related factors.
- High levels of type 1 plasminogen activator inhibitor (PAI-1), lipoprotein(a), and hyperhomocysteinemia are implicated in CRVO pathogenesis.
- Data on some parameters remain contradictory, necessitating further investigation.
Impact:
- Identifies key hemostasis markers (PAI-1, lipoprotein(a), hyperhomocysteinemia) contributing to CRVO.
- Suggests potential for improved prognostic assessment in CRVO patients.
- Opens avenues for novel therapeutic strategies targeting these specific pathways.
Abstract:
Retinal vein occlusion is a relatively common disease, usually associated with the presence of diseases related to internal medicine. Central retinal vein occlusion is the most frequently-occurring and clinically relevant type. In addition to the well-known classic risk factors, new hemostasis-related ones have been investigated in patients affected by central retinal vein occlusion. While data concerning a number of parameters remain contradictory, high levels of type 1 plasminogen activator inhibitor (PAI-1) and lipoprotein(a) and hyper-homocystinemia appear to play a significant role in the pathogenesis of this disease. Although based on a limited number of studies, this new knowledge could eventually provide important indications regarding prognosis and therapeutic strategies.
More Related Videos
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview

